Bausch & Lomb Incoporated
NDC labeler code: 24208
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- Neomycin sulfate, polymyxin b sulfate and hydrocortisoneNeomycin and Polymyxin B Sulfates and Hydrocortisone, Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension, Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic · 1 product
- Sulfacetamide sodium and prednisolone sodium phosphate1 product
FDA applications for these products
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| December 29, 1995 | ANDA064053 | Neomycin sulfate, polymyxin b sulfate and hydrocortisone NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE | Bausch and Lomb Inc |
| December 29, 1995 | ANDA074449 | Sulfacetamide sodium and prednisolone sodium phosphate SULFACETAMIDE SODIUM AND PREDNISOLONE SODIUM PHOSPHATE | Bausch and Lomb |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
2024
-
September 11, 2024 · Class II · Terminated · D-0661-2024 · Proparacaine hydrochloride
Temperature abuse: Products exposed to improper temperature above drug label specifications.
Proparacaine Hydrochloride Ophthalmic Solution, USP 0.5% (sterile), 15 mL bottle, Rx only, MFG: Bausch & Lomb, NDC 24208-730-06
2019
-
June 17, 2019 · Class III · Terminated · D-1396-2019 · Loteprednol etabonate
Failed Stability Specifications: Out of specification for viscosity.
Lotemax (loteprednol etabonate ophthalmic gel 0.5%), Sterile, Rx Only, 5 g box, Bausch & Lomb, a division of Valeant Pharmaceuticals North America LLC Bridgewater, NJ 08807 USA, NDC 24208-503-07.
2016
-
January 18, 2016 · Class III · Terminated · D-0645-2016 · Cyclopentolate hydrochloride
Labeling: Incorrect or Missing Package Insert: Package insert is missing updates compared with reference drug insert.
Cyclopentolate Hydrochloride Ophthalmic Solution USP, 1%, Packaged in a) 2 mL Bottles (NDC: 24208-735-01) and b) 15 mL Bottles (NDC: 24208-735-05), Rx Only. Bausch and Lomb Incorporated, Tampa, FL, 33637.
-
January 18, 2016 · Class III · Terminated · D-0646-2016 · Tropicamide
Labeling: Incorrect or Missing Package Insert: Package insert is missing updates compared with reference drug insert.
Tropicamide Ophthalmic Solution USP, 0.5%, Packaged in 15 mL Bottles, Rx Only. Bausch and Lomb Incorporated, Tampa, FL, 33637. NDC: 24208-590-64.
-
January 18, 2016 · Class III · Terminated · D-0647-2016 · Tropicamide
Labeling: Incorrect or Missing Package Insert: Package insert is missing updates compared with reference drug insert.
Tropicamide Ophthalmic Solution USP, 1%, Packaged in a) 2 mL Bottles (NDC: 24208-585-59) and b) 15 mL Bottles (NDC: 24208-585-64), Rx Only. Bausch and Lomb Incorporated, Tampa, FL, 33637.
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Next steps
- Find a pharmacy near youAsk which company made your medicine and whether it is recalled
- Latest FDA drug recallsAll companies, newest first
- All drug companiesA to Z
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026